GGHYX Fees and Costs — Invesco Health Care Fund, Class Y
Data updated: 2026-09-28
The net expense ratio is 0.82%: a 0.64% management fee plus 0.17% other expenses. There are no sales loads or redemption fees. In fiscal 2025 the fund paid $519K in broker commissions, 0.0424% of average net assets, and portfolio turnover was 56%.
GGHYX Fees and Expenses
Annual operating expenses and sales charges of GGHYX. Prospectus, as of February 28, 2026.
| Annual operating expenses | |
|---|---|
| Management fee | 0.64% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.17% |
| Gross expense ratio | 0.82% |
| Fee waiver | — |
| Net expense ratio | 0.82% |
| Sales charges | |
|---|---|
| Max front load | 0.00% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
GGHYX Costs Over Time
On $10,000 invested in GGHYX, assuming 5% a year before costs, total costs come to $541 over 5 years, cutting the return by 0.91% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.82%) | $86 | $269 | $467 |
| Trading costs (broker commissions) | $4 | $14 | $24 |
| Lost growth on money paid in costs | $0 | $14 | $50 |
| Total costs | $91 | $297 | $541 |
| Value after costs | $10,409 | $11,279 | $12,222 |
| Impact on return, per year | 0.91% | 0.91% | 0.91% |
GGHYX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.0424%
- Total broker commissions: $519K
- Bought from dealers (principal trades, not a cost): $11.2M
- Portfolio turnover (prospectus): 56%
- Securities on loan, average value: $41.4M
- Net income from securities lending: $98K (0.008% of average net assets)
GGHYX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| MERRILL LYNCH, PIERCE, FENNER & SMITH INC. | $82K | 20.64% |
| INVESCO CAPITAL MARKETS, INC. | $76K | 19.24% |
| UBS SECURITIES LLC | $59K | 14.90% |
| J.P. MORGAN SECURITIES LLC | $39K | 9.92% |
| GOLDMAN, SACHS & CO. | $32K | 8.19% |
| MORGAN STANLEY & CO. LLC | $28K | 7.05% |
| JEFFERIES LLC | $23K | 5.72% |
| BARCLAYS CAPITAL INC. | $21K | 5.27% |
| WELLS FARGO SECURITIES, LLC | $20K | 4.98% |
| SANFORD C. BERNSTEIN & CO., LLC | $16K | 4.08% |
GGHYX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| BOFA SECURITIES, INC. | $4.5M | 40.38% |
| J.P. MORGAN SECURITIES LLC | $3.8M | 34.29% |
| GOLDMAN, SACHS & CO. | $2.8M | 25.33% |
Invesco Health Care Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| GGHSX | Class R6 | 0.72% | none |
| GGHYX | Class Y | 0.82% | none |
| GGHCX | Class A | 1.07% | 5.50% |
| GTHIX | Investor Class | 1.07% | none |
| GTHRX | Class R | 1.32% | none |
| GTHCX | Class C | 1.82% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.